The prognostic biomarkers for multiple myeloma (MM) was urgently needed, and this study was the first to confirm the value of Intravoxel Incoherent Motion-Diffusion Weighted Imaging (IVIM-DWI) for predicting progression-free survival in patients with MM.Purpose: To evaluate the prognostic ability of Intravoxel Incoherent Motion-Diffusion Weighted Imaging (IVIM-DWI) derived parameters in newly diagnosed multiple myeloma (MM).
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords